Cerus (CERS) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cerus Corporation  (NASDAQ: CERS)


Cerus's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Cerus's ROA in the second quarter of 2026?
Cerus Corporation recorded a cumulative net loss of $-7 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -3.15%.

However, within the Healthcare sector 242 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 2939, from total ROA ranking in the first quarter of 2026 at 3602.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -4.21 % 8 % 10.92 % 13.18 % 14.65 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -7 -10 -16 -16 -19
Return On Assets (TTM) -3.15 % -4.37 % -7.27 % -7.64 % -9.32 %
CERS's Total Ranking # 2939 # 3602 # 3188 # 3267 # 3306
Total Assets (TTM) in million 205 224 222 216 214
Seq. Total Assets Change -8.21 % 0.47 % 2.93 % 0.91 % 3.49 %
Seq. Net Income Change - - - - -

CERS's 5 Years Annual ROA >> Back to CERS Management Effectiveness >> Compare CERS ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 77
Sector # 243
Overall # 2833

Return On Assets Statistics
High Average Low
-3.16 %
-32.99 %
-67.86 %
(Jun 30 2026)   (Sep 30 2017)



  News about Cerus Corporation Return on Assets ROA

Embracing the Future of Blood Safety Cerus Corporations Dual Commitment in the U.S. and Europe

In an increasingly interconnected world, the safety and accessibility of blood transfusions remain paramount. Cerus Corporation, a key player in this field, is making significant strides with its INTERCEPT red blood cell (RBC) programs, catering to both the United States and European markets. Recent announcements from the company underline its commitment to enhancing blood safety for patients in need. U.S. Developments: A $248 Million Boost from BARDAOn the American front, Cerus has announced a remarkable $248 million contract with the Biomedical Advanced Research and Development Authority (BARDA). This substantial funding is aimed at propelling the INTERCEPT RBC program beyond its ongoing Phase 3 studies, paving the way towards Pre-Market Approval (PMA) licensure and eventual commercialization. Such government support signals confidence in the potential of INTERCEPT technology to revolutionize blood transfusion practices, providing safer blood products with reduced risks of transfusion-transmissible infections.



Financial Statements
Cerus's Assets $ 205 million CERS's Balance sheet
Cerus's Income $ -3 million Quarterly CERS's Income Statement
CERS's Income by Division See CERS's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 10.92 % 0.74 % -9.44 % -7.42 % 7.26 %
Total Assets in million 222 201 199 220 237
Y / Y Net Income Change - - - - -
Net Income in million -16 -21 -38 -43 -54
Annual Return On Assets -7.03 % -10.45 % -18.91 % -19.48 % -22.9 %

CERS's 5 Years Annual ROA >> Back to CERS Management Effectiveness >> Compare CERS ROA to its Competitors



More Return On Assets Ratios
CERS's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CERS's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CERS's Competitors
Subscribers only: Roa for Cerus's Suppliers
Subscribers only: Return On Assets for CERS's Customers

You may also want to know
CERS's Roi CERS's Inventory Turnover Ratio CERS's Growth Rates CERS's Dividend Comparisons
CERS's Profitability Ratios CERS's Asset Turnover Ratio CERS's Dividend Growth
CERS's Roe CERS's Valuation Ratios CERS's Financial Strength Ratios CERS's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-14T03:49:53+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.